Q1 2019 BioArctic AB Earnings Call Transcript
Hello, and welcome to the BioArctic Q1 2019 Report. (Operator Instructions) Just to remind you, this conference call is being recorded.
Today, I'm pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. Please go ahead with your meeting.
()-
Thank you so much, and I'm happy to be here today and present the interim report from January to March 2019, and I will share the presentation with our CFO, Jan Mattsson.
Next slide, please. So BioArctic, here we are on the dot com -- NASDAQ.com exchange, and that -- this is our disclaimer. Next slide, please.
So today, I will start with a summary of our great projects -- progress in the projects for 2018 and for the beginning of this year. And I think we have had a great projects in all 3 disease areas as well as with our technology platform in the blood-brain bio market.
I will start with Alzheimer's disease, where BAN2401 with our -- is our most advanced program. Last summer, we presented positive result
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |